Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Yasushi Omuro"'
Autor:
Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, An Ohigashi, Yuka Morita, Taichi Tamura, Shohei Nakamura, Akihiko Kageyama, Yasushi Omuro, Tatsu Shimoyama
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Synchronous multiple primary malignant tumors (sMPMTs) are sometimes diagnosed in patients with malignant lymphoma. We herein investigated the prognostic impact of sMPMT in lymphoma patients and the optimal treatment strategy. Met
Externí odkaz:
https://doaj.org/article/6923958f8d2a49c0a3bda467c6d223dd
Autor:
Ryo Negishi, Hitomi Yamakawa, Takeru Kobayashi, Mayuko Horikawa, Tatsu Shimoyama, Fumiaki Koizumi, Takeshi Sawada, Keisuke Oboki, Yasushi Omuro, Chikako Funasaka, Akihiko Kageyama, Yusuke Kanemasa, Tsuyoshi Tanaka, Tadashi Matsunaga, Tomoko Yoshino
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-12 (2022)
Ryo Negishi et al. utilize a size-dependent recovery method with gel-based cell manipulation to isolate single circulating tumor cells (CTCs) for transcriptomic analysis. They demonstrate the utility of this approach by analyzing the transcriptomic p
Externí odkaz:
https://doaj.org/article/a86e30aadf1544eabe472e2a9f2ede17
Autor:
Mao Uematsu, Yusuke Kanemasa, Shohei Nakamura, Chikako Funasaka, Akihiko Kageyama, Tatsu Shimoyama, Yasushi Omuro
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 3, Pp 928-934 (2019)
Choriocarcinoma is a highly aggressive germ cell tumor and can metastasize to the brain. Although brain metastasis has a poor prognosis, the optimal treatment strategy remains unclear due to its low incidence. A 33-year-old man presenting with multip
Externí odkaz:
https://doaj.org/article/86f8cb3e5b6743588f4195fdb61abfac
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 2, Pp 657-665 (2019)
Fluorouracil plus oxaliplatin (L-OHP) (FOLFOX) plus bevacizumab (BV) therapy is commonly administered to patients with metastatic colorectal cancer. However, few reports have described L-OHP therapy in hemodialysis patients, and the efficacy and safe
Externí odkaz:
https://doaj.org/article/f62801f1cdc8473f911832eaa046a8df
Autor:
Kei Muro, Kohei Shitara, Kensei Yamaguchi, Takaki Yoshikawa, Hironaga Satake, Hiroki Hara, Naotoshi Sugimoto, Nozomu Machida, Masahiro Goto, Hisato Kawakami, Kenji Amagai, Yasushi Omuro, Taito Esaki, Shuichi Hironaka, Tomohiro Nishina, Yoshito Komatsu, Hisahiro Matsubara, Shinichi Shiratori, Shirong Han, Taroh Satoh, Atsushi Ohtsu
Publikováno v:
Journal of Gastrointestinal Cancer.
Purpose Pembrolizumab demonstrated antitumor activity in programmed death ligand 1 positive (combined positive score (CPS) ≥ 1) gastric/gastroesophageal junction cancer in KEYNOTE-059 (third line or beyond), KEYNOTE-061 (second line), and KEYNOTE-0
Autor:
Yu, Yagi, Yusuke, Kanemasa, Yuki, Sasaki, Yudai, Hayashi, Mano, Mino, Chika, Kato, Satoshi, Sakai, An, Ohigashi, Yasuhiro, Kanbara, Yuka, Morita, Taichi, Tamura, Yuya, Atsuta, Ryosuke, Konuma, Shohei, Nakamura, Atsushi, Wada, Toshihiro, Okuya, Akihiko, Kageyama, Daisuke, Murakami, Shiori, Nakashima, Yusuke, Uchibori, Daishi, Onai, Atsushi, Hamamura, Akihiko, Nishijima, Yasushi, Omuro, Naoki, Shingai, Takuya, Shimizuguchi, Takashi, Toya, Hiroaki, Shimizu, Yuho, Najima, Takeshi, Kobayashi, Kyoko, Haraguchi, Kazuteru, Ohashi, Noriko, Doki, Yoshiki, Okuyama, Tatsu, Shimoyama
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 63(10)
Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the approach to patients with relapsed or refractory diffuse large B-cell lymphoma (r/r DLBCL). This study retrospectively analyzed patients treated with commercially available tisagen
Autor:
Kensei Yamaguchi, Keiko Minashi, Daisuke Sakai, Tomohiro Nishina, Yasushi Omuro, Masahiro Tsuda, Shiroh Iwagami, Hisato Kawakami, Taito Esaki, Naotoshi Sugimoto, Takashi Oshima, Ken Kato, Kenji Amagai, Hisashi Hosaka, Keigo Komine, Hisateru Yasui, Yuji Negoro, Kenji Ishido, Takahiro Tsushima, Shirong Han, Shinichi Shiratori, Tomoko Takami, Kohei Shitara
Publikováno v:
Cancer science. 113(8)
The KEYNOTE-659 study evaluated the efficacy and safety of first-line pembrolizumab plus S-1 and oxaliplatin (SOX) (cohort 1) or S-1 and cisplatin (SP) (cohort 2) for advanced gastric/gastroesophageal junction (G/GEJ) cancer in Japan. Herein, we upda
Autor:
Tatsu Shimoyama, Shohei Nakamura, Mao Uematsu, Chikako Funasaka, Yasushi Omuro, Yusuke Kanemasa, Akihiko Kageyama
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 3, Pp 928-934 (2019)
Case Reports in Oncology
Case Reports in Oncology
Choriocarcinoma is a highly aggressive germ cell tumor and can metastasize to the brain. Although brain metastasis has a poor prognosis, the optimal treatment strategy remains unclear due to its low incidence. A 33-year-old man presenting with multip
Autor:
Nobumasa Mizuno, Masafumi Ikeda, Yasushi Omuro, Makoto Ueno, Tatsuya Ioka, Fumio Nagashima, Shinichi Ohkawa, Takako Eguchi Nakajima, Hideki Ueno, Junji Furuse
Publikováno v:
Internal Medicine
Gemcitabine plus nab-paclitaxel is the current standard chemotherapy for patients with metastatic pancreatic cancer. We conducted a phase I/II study in Japan, in which high response rates and manageable toxicity were observed. In this study, two pati
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 12, Iss 2, Pp 657-665 (2019)
Case Reports in Oncology, Vol 12, Iss 2, Pp 657-665 (2019)
Fluorouracil plus oxaliplatin (L-OHP) (FOLFOX) plus bevacizumab (BV) therapy is commonly administered to patients with metastatic colorectal cancer. However, few reports have described L-OHP therapy in hemodialysis patients, and the efficacy and safe